Stereotaxis Announces First GenesisX Robotic System Order

ST. LOUIS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it has received the first order for its latest generation robotic system, GenesisX™. "We are thrilled to announce the first firm order for GenesisX from a pioneering European hospital," said David Fischel, Stereotaxis Chairman and CEO. "Establishing the first GenesisX robotic lab is a critical milestone for us as we advance t ...